tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sionna Therapeutics initiated with a Strong Buy at Raymond James
PremiumThe FlySionna Therapeutics initiated with a Strong Buy at Raymond James
10d ago
Short Report: C3.AI short positioning at 2025-high
Premium
The Fly
Short Report: C3.AI short positioning at 2025-high
10d ago
Sionna Therapeutics announces first subjects dosed in Phase 1 trial on SION-451
Premium
The Fly
Sionna Therapeutics announces first subjects dosed in Phase 1 trial on SION-451
19d ago
Sionna Therapeutics reports Q1 EPS (62c), consensus (45c)
PremiumThe FlySionna Therapeutics reports Q1 EPS (62c), consensus (45c)
4M ago
Sionna Therapeutics sees cash runway into 2028
Premium
The Fly
Sionna Therapeutics sees cash runway into 2028
4M ago
Sionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last year
Premium
The Fly
Sionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last year
6M ago
Innovative Approach to Cystic Fibrosis Treatment: Sionna Therapeutics’ Pioneering Pipeline Earns Buy Rating
PremiumRatingsInnovative Approach to Cystic Fibrosis Treatment: Sionna Therapeutics’ Pioneering Pipeline Earns Buy Rating
6M ago
Sionna Therapeutics initiated with a Buy at Stifel
Premium
The Fly
Sionna Therapeutics initiated with a Buy at Stifel
6M ago
Sionna Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Sionna Therapeutics initiated with a Buy at Guggenheim
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100